In a Czech Republic population with IB-III NSCLC, patients with more LC3A-positive stone-like structures were significantly more likely to have the poor OS and disease-free survival (DFS) [26]. The gene discussed is MAP1LC3A; the disease is non-small cell lung carcinoma.